T. Mazaki et al., MUTATIONS OF P53, E-CADHERIN, ALPHA-CATENIN AND BETA-CATENIN GENES AND TYROSINE PHOSPHORYLATION OF BETA-CATENIN IN HUMAN GASTRIC CARCINOMAS, International journal of oncology, 9(3), 1996, pp. 579-583
We investigated whether dysfunction of p53 and E-cadherin participate
in invasiveness and metastasis of human gastric carcinoma. We examined
twenty-five human gastric carcinomas for p53, E-cadherin, alpha- and
beta-catenin gene alteration by the reverse transcription-polymerase c
hain reaction-single strand conformation polymorphism (RT-PCR-SSCP) me
thod and sequencing analysis. Three samples (13%) showed p53 gene muta
tion (two missense mutations and 6 bp deletion). 25% (3/12) of the car
cinomas with lymph node metastasis had p53 gene mutations. One sample
(4%) showed E-cadherin silent mutation. We were not able to detect alp
ha- or beta-catenin gene alteration. Therefore we investigated tyrosin
e-phosphorylation of E-cadherin, a and beta-catenin. Tyrosine-phosphor
ylated beta-catenin was detected in 13% (2/15) of poorly differentiate
d carcinomas. These results suggest that the p53 gene mutations have s
ome correlation with lymph node metastasis, and tyrosine phosphorylati
on of beta-catenin rather than cadherin/catenin gene mutation is at le
ast partly responsible for the loosening of cell-cell contact and inva
siveness of poorly differentiated carcinomas.